Skip to content
value.today

KitoTech Medical, Inc.

Formerly Marco Pharmaceuticals, Inc.

Total raised
$19 M
4 rounds on record
Latest round
$13 M
Nov 2021
First round on record
Dec 2014
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of KitoTech Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2021$13 MNo. 4$10 to $50 million

KitoTech Medical, Inc.: Raise no. 4, Nov 2021

Investors in this round

153 investors had bought by the notice of Dec 3, 2021: 153 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $18 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ronald Berenson · Executive Officer, Director
  • Edward Truitt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ronald Berenson, Ceo. Source: SEC Form D, newest notice filed Dec 3, 2021. Read the notice at the SEC.

equitySEC
Jun 2019$2 MNo. 3$2 to $10 million

KitoTech Medical, Inc.: Raise no. 3, Jun 2019

Investors in this round

25 investors had bought by the notice of Aug 12, 2020: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ron Berenson · Executive Officer, Director
  • Ed Truitt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ronald Berenson, President and CEO. Source: SEC Form D, newest notice filed Aug 12, 2020. Read the notice at the SEC.

debt, optionsSEC
Dec 2017$2 MNo. 2Under $2 million

KitoTech Medical, Inc.: Raise no. 2, Dec 2017

Investors in this round

69 investors had bought by the notice of Nov 2, 2018: 69 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ronald Berenson · Executive Officer, Director
  • Cameron Pollock · Director
  • Ed Truitt · Director
  • Jens Quistgaard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ronald Berenson, CEO and President. Source: SEC Form D, newest notice filed Nov 2, 2018. Read the notice at the SEC.

debt, optionsSEC
Dec 2014$2 MNo. 1Under $2 million

KitoTech Medical, Inc.: Raise no. 1, Dec 2014

Investors in this round

32 investors had bought by the notice of Jan 8, 2015: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$25,637
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ronald Berenson · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • RainMaker Securities LLC (CRD 132995) · Chicago, IllinoisSold in IL
  • Marketshare Management, Inc. · Chevy Chase, MarylandSold in CA, CT, NJ, NY, VA

Signed by Ronald Berenson, Ceo. Source: SEC Form D, newest notice filed Jan 8, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • KitoTech Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2021).

    SEC Form D · Dec 2021

  • The industry group it chose in its notices: Other.

    SEC Form D · Dec 2021

That is all the official record says: KitoTech Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of KitoTech Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 153 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by KitoTech Medical, Inc.
NameRoleNamed in
Ronald BerensonExecutive officerDec 2021
Ron BerensonExecutive officerAug 2020
Edward TruittDirectorDec 2021
Ronald BerensonDirectorDec 2021
Ed TruittDirectorAug 2020
Ron BerensonDirectorAug 2020
Cameron PollockDirectorNov 2018
Jens QuistgaardDirectorNov 2018
Ronald BerensonPromoterJan 2015